Common side effects of Brigatinib
Sep 11,2019
Brigatinib (marketed as Alunbrig) is a small-molecule targeted cancer therapy being developed by ARIAD Pharmaceuticals, Inc. Brigatinib acts as both a anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR) inhibitor. Brigatinib could overcome resistance to osimertinib conferred by the EGFR C797S mutation if it is combined with an anti-EGFR antibody such as cetuximab or panitumumab.
Use
Brigatinib is used for the treatment of metastatic anaplastic lymphoma kinase positive non-small cell lung cancer in patients who have progressed on or are intolerant of crizotinib.
Brigatinib comes as a tablet to take by mouth. It is usually taken with or without food once daily. Take brigatinib at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take brigatinib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
lung problems--cough, trouble breathing, chest pain, fever;
vision problems--blurred vision, double vision, increased sensitivity to light, seeing flashes of light or "floaters" in your vision;
high blood pressure--severe headache, pounding in your neck or ears, nosebleed;
high blood sugar--increased thirst, increased urination, hunger, nausea, fruity breath odor, weakness, confusion;
heart problems--very slow heartbeats, feeling like you might pass out;
muscle problems--unexplained muscle pain or weakness; or pancreatitis--severe pain in your upper stomach spreading to your back, nausea,
weight loss.
Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.
Common side effects may include: nausea, diarrhea; cough; headache; or feeling tired. This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
- Related articles
- Related Qustion
- Brigatinib: Indications, Dosing, Mechanism of Action and Side Effects Dec 16, 2024
Brigatinib is a new generation anaplastic lymphoma kinase (ALK) inhibitor.
- Brigatinib: Development History and Preclinical Studies Nov 19, 2024
Brigatinib, a crucial treatment for NSCLC patients with EGFR and ALK mutations, effectively inhibits ALK with unique features, overcoming resistance and offering hope in lung cancer treatment.
- The warnings and precautions of Brigatinib Mar 6, 2024
ALUNBRIG (Brigatinib) is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.
Trimethylaluminum and related alkylaluminum reagents are pyrophoric materials that can react explosively with the moisture in tissues, causing severe burns.....
Sep 10,2019Organic ChemistryCarbon monoxide is a colorless, odorless, tasteless, flammable, toxic gas.Carbon monoxide is produced when carbon and carbon compounds undergo incomplete combustion. The inefficient combustion of carbon fuels for heating results in the prod....
Sep 11,2019Inorganic chemistryBrigatinib
1197953-54-0You may like
- Brigatinib
- $0.00 / 100g
- 2025-01-06
- CAS:1197953-54-0
- Min. Order: 50g
- Purity: 99%
- Supply Ability: 8kgs
- Brigatinib
- $0.00 / 1kg
- 2025-01-02
- CAS:1197953-54-0
- Min. Order: 1kg
- Purity: 99.0%
- Supply Ability: 10000
- Brigatinib
- $0.00 / 1g
- 2024-12-30
- CAS:1197953-54-0
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 100kg/Month